Showing results (671-680 of 3,348) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|November 15, 2018
Autologous Chondrocyte Implantation with Chondrosphere for Treating Articular Cartilage Defects in the Knee: An Evidence Review Group Perspective of a NICE Single Technology AppraisalXavier Armoiry, Ewen Cummins, Martin Connock, et al.
Pharmacoeconomics|November 15, 2018
Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalBram L T Ramaekers, Rob Riemsma, Sabine Grimm, et al.
Pharmacoeconomics|October 28, 2018
Does a Patient-Directed Financial Incentive Affect Patient Choices About Controller Medicines for Asthma? A Discrete Choice Experiment and Financial Impact AnalysisTracey-Lea Laba, Helen K Reddel, Nicholas J Zwar, et al.
Pharmacoeconomics|October 28, 2018
Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic ReviewEdward T Chiyaka, Van T Nghiem, Lu Zhang, et al.
Pharmacoeconomics|November 3, 2018
Cost-Effectiveness Analysis of Direct-Acting Oral Anticoagulants for Stroke Prevention in Thai Patients with Non-Valvular Atrial Fibrillation and a High Risk of BleedingThananan Rattanachotphanit, Chulaporn Limwattananon, Onanong Waleekhachonloet, et al.
Pharmacoeconomics|November 11, 2018
Determining Value in Health Technology Assessment: Stay the Course or Tack Away?J Jaime Caro, John E Brazier, Jonathan Karnon, et al.
Pharmacoeconomics|February 17, 2017
Making Implicit Assumptions Explicit in the Costing of Informal Care: The Case of Head and Neck Cancer in IrelandPaul Hanly, Rebecca Maguire, Myles Balfe, et al.
Pharmacoeconomics|February 27, 2017
Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities?Paul Mark Mitchell, Sridhar Venkatapuram, Jeff Richardson, et al.
Pharmacoeconomics|March 25, 2017
An Early Health Economic Analysis of the Potential Cost Effectiveness of an Adherence Intervention to Improve Outcomes for Patients with Cystic FibrosisPaul Tappenden, Susannah Sadler, Martin Wildman
Pharmacoeconomics|March 14, 2019
An Examination of Downstream Effects of Bereavement on Healthcare Utilization for Surviving Spouses in a National Sample of Older AdultsKatherine A Ornstein, Melissa M Garrido, Albert L Siu, et al.
Pageof 335